Press Release|

SHL Group reaches major milestone of 3,000 employees

Shl Reached 3000 Employee Milestone 800x480

Within just two years of reaching a milestone of 2,500 employees, SHL Group has rapidly reached 3,000 employees worldwide. This increase is reflective of a steady yet rapid growth in the injectable drug delivery market and SHL’s effective commitment, productivity, and management.

A global leader in the design and manufacturing of autoinjectors and pen injectors, SHL offers innovative designs, robust manufacturing capabilities, a lean supply chain, strong partnerships, and more. With offices and manufacturing facilities located in Taiwan, Sweden, the US and China, SHL aims for the highest product and service quality, better brand recognition, and building of business values for employees and customers.

Over the years, SHL has continuously invested in R&D and manufacturing capabilities, and currently houses more than 180 high precision molding machines selected from leading brands worldwide. With expert engineers operating such state-of-the-art equipment, SHL has been able to meet increasing customer demands for response time, quality, and capacity.

“SHL is committed to developing innovative devices and providing exceptional customer service, thus we never hesitate when it comes to further investments and expansions if it means providing better quality and capacity for our customers,” said Roger Samuelsson, President and CEO of SHL Group. “We have been extending and expanding our services and production sites over the years, and will continue to do so to accommodate future needs. Reaching 3,000 employees in such a short time is a true milestone for us and we look forward to bringing more leading-edge technology to market in such areas as autoinjectors and pen injectors, inhalers, connectivity, and much more.”

At present, SHL works with 80% of the world’s top 25 pharmaceutical companies. Its sites expand across Sweden, the US, Taiwan, and China. Currently there are nine major production sites in Taiwan.

About SHL Medical

As a world-leading solutions provider of advanced drug delivery systems, SHL Medical is the partner of choice for many leading pharma and biotech companies. Driven by our company purpose – Enabling Patients’ Independence – we offer patient-centric solutions for the design, development, and manufacturing of autoinjectors, pen injectors, as well as innovative specialty delivery systems for large-volume and high-viscosity formulations. We also offer final assembly, labeling, and packaging solutions for our drug delivery systems.  ​

In response to the rising trend in home therapy, SHL has increased developmental work in the digital healthcare sector to help improve the drug delivery ecosystem

Located across Switzerland, Taiwan, Sweden, and the US, our global team of experts collaborate seamlessly as one team in utilizing our comprehensive in-house manufacturing capabilities. Our solutions offer customization and optimization for each project while proactively weaving sustainability-driven measures into our designs and processes to contribute to a cleaner earth.​

For additional information, visit www.shl-medical.com

Media contact: info@shl-medical.com

Share:

Related News